Showing results (261-270 of 282) with videos related to

Sort By:
Pageof 29
Gastrointestinal Endoscopy|October 22, 2023
Preoperative endoscopic biliary drainage by metal versus plastic stents for resectable perihilar cholangiocarcinomaDavid M de Jong, Timothy M Gilbert, Lynn E Nooijen, et al.
Archives of Toxicology|April 4, 2016
Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profileJames A Heslop, Cliff Rowe, Joanne Walsh, et al.
Digestive Surgery|April 16, 2025
Current Practice in the Treatment of Colorectal Liver Metastases by Irreversible Electroporation: An International Questionnaire Survey (LIVERMET-IRE-Q)Harry V M Spiers, Saurabh Jamdar, Santhalingam Jegatheeswaran, et al.
ESMO Open|October 22, 2023
A comparison of the efficacy of trastuzumab deruxtecan in advanced HER2-positive breast cancer: active brain metastasis versus progressive extracranial disease aloneJ Pearson, A Khan, T Bhogal, et al.
Cancer Chemotherapy and Pharmacology|June 13, 2013
Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II studyR P Jones, P Sutton, R M D Greensmith, et al.
International Journal of Obesity (2005)|August 10, 2017
l-phenylalanine modulates gut hormone release and glucose tolerance, and suppresses food intake through the calcium-sensing receptor in rodentsA Alamshah, E Spreckley, M Norton, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 16, 2019
European Society of Surgical Oncology's strategy for clinical research: Paving the way for a culture of research in cancer surgeryS Evrard, C van de Velde, I Noordhoek, et al.
Gut|September 28, 2023
British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinomaSimon M Rushbrook, Timothy James Kendall, Yoh Zen, et al.
Free Radical Biology & Medicine|December 3, 2014
Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2Adedamola Olayanju, Ian M Copple, Holly K Bryan, et al.
European Urology Oncology|July 12, 2025
Efficacy of Anti-PD-(L)1 Immunotherapy in Patients with DNA Mismatch Repair-deficient Metastatic Castration-resistant Prostate CancerSandra van Wilpe, Tarek Taha, Emily C Rothmann, et al.
Pageof 29